Background: Alcohol is capable of traversing the blood-brain barrier and is thus a possible risk factor for brain cancer. Several epidemiological studies have been published on the issue, a number of those during recent years, with inconsistent findings.
introduction
Brain and other nervous system tumours are, after stroke, the second cause of death from neurological diseases. Gliomas and meningiomas are the most common subtypes, accounting for over 80% of cases [1] .
Exposure to ionizing radiations and a few hereditary cancer syndromes are among the few identified aetiological factors for brain tumours, but the corresponding proportion of attributable cancers is minimal. Other potential, but largely unconfirmed, risk factors include head and acoustic traumas, selected infectious-mainly viral-agents, history of allergic conditions ( potential inverse relation), several occupational exposures, dietary and other exposures to N-nitroso compounds, and use of mobile phones, though recent investigations did not support the last two hypotheses [2] [3] [4] . For other factors as well, the evidence is still inconclusive [1, 5] .
Alcohol is capable of traversing the blood-brain barrier and is thus a possible risk factor for brain cancer, besides being an established factor for several other cancers and diseases [6] [7] [8] . Ethanol is oxidized to acetaldehyde, a genotoxic metabolite, in the brain, too [9] . Alcohol consumption has been investigated in relation to adult brain cancer risk in a number of studies since the early 1970s [10] , with generally inconsistent results for both overall consumption and for different types of alcoholic beverages. A number of studies on the issue have been published during the last 3 years [11] [12] [13] [14] [15] . An Australian cohort study of glioblastoma-i.e. the subtype of brain cancer with lowest survival rates-reported a dose-risk relation with increasing alcohol drinking [12] . The hazard ratios (HR) were 1.07 for 1-19 g/day, 1.79 for 20-39 g/day, 3.07 for 40-59 g/day, and 2.54 for ≥60 g/day of alcohol consumption (P < 0.01), when compared with never drinkers. The results were similar for beer and wine consumption. On the other hand, no association emerged in the UK Million Women Study, based on 908 brain cancer cases, reporting a relative risk (RR) of 1.17 for consumption of ≥15 drinks per week when compared with occasional drinking (i.e. ≤2 drinks/week) [11] .
Worldwide, ∼390 000 (3.6%) cancers and 230 000 (3.5%) cancer deaths were attributable to alcohol drinking in 2002 [16] . To our knowledge, no study provided attributable risk estimates for brain cancer.
With the aim of summarizing the evidence on alcohol consumption and adult brain cancer, also according to different tumour sub-types, we conducted a systematic review and meta-analysis of available data on the issue.
materials and methods
We carried out the meta-analysis following the guidelines from the Metaanalysis of Observational Studies in Epidemiology Group [17] . In September 2011, two authors (CP and SM) independently performed a systematic literature search in the Medline and EMBASE databases, using the search strings reported in Supplementary File 1, available at Annals of Oncology online. The same authors retrieved and independently assessed potentially relevant articles reporting information on the association between alcohol or alcoholic beverage consumption and brain cancer incidence or mortality, and checked the reference list of all papers of interest to retrieve other pertinent publications. Abstract and unpublished studies were not included. No studies were excluded a priori for weakness of design or data quality. We applied the following inclusion criteria: (i) original cohort and case-control studies on adult brain cancer; (ii) availability of a quantitative estimate [odds ratio (OR), RR, or HR] of the relation between alcohol or alcoholic beverage consumption and brain cancer; (iii) availability of at least one of the following: the 95% confidence intervals (CI), or standard error, or the distribution of cases and non-cases in alcohol consumption categories; (iv) when multiple reports were published on the same study population, we included in the meta-analysis only the most informative one (except for the Million Women Study, that provided relevant results for brain tumours and their main subtypes in separate publications [11, 18] ). Each publication identified in this process was examined to extract relevant information.
We reviewed all the studies and abstracted the following information in a standard format: study design; country; period of enrolment (casecontrol studies) and/or follow-up (cohort studies); number of subjects (cases, controls or non-cases or cohort size); gender; availability of data on total alcohol and specific alcoholic beverages; tumour subtypes; covariates adjusted for in the analysis; risk estimates (ORs or RRs, collectively referred to as RRs) and the corresponding 95% CIs or standard errors; and, when available, the number of cases and non-cases for each category of consumption of alcohol/alcoholic beverages.
In the analyses on amount of alcohol drinking, we used the midpoint of each category of alcohol consumption for each study.
For upper, openended exposure categories, we used 1.2-fold its lower bound [19] . Grams of ethanol were used as measure for the analyses, defining one drink as 12.5 g of ethanol, if not otherwise specified in the original report, 1 ml as 0.8 g, and 1 oz as 28.35 g of ethanol. We used non-drinkers as reference category. We defined moderate alcohol intake as <25 g of ethanol per day, i.e. <2 drinks per day, and heavy intake as ≥25 g of ethanol per day. When more than one estimate in a study fell in the range considered for moderate or heavy alcohol drinking, we pooled the corresponding estimates using the Hamling et al. method [20] , thus taking into account their correlation.
We calculated summary estimates of the RR using random-effects models [i.e. as weighed averages using the inverse of the sum of the variance of the log(RR) and the moment estimator of the variance between studies as weight] [21] . Heterogeneity between studies was assessed using the χ 2 test, defined as a P < 0.10, and inconsistency was measured using also the I 2 statistic [22] . In order to investigate possible sources of heterogeneity among studies, we carried out a cumulative meta-analysis over time and we computed summary estimates in strata of sex, geographic area, study design, tumour subtype, and type of outcome. The presence of publication bias was assessed by examination of funnel plot and by applying the tests proposed by Begg and Mazumdar [23] , and by Egger [24] . All the statistical analyses were carried out using the STATA software (version 11; StataCorp., College Station, TX, USA).
results
The flowchart for literature search and selection of articles is reported in Supplementary File 2, available at Annals of Oncology online. A total of 2261 (non-unique) articles were first identified by review team members. Most of them were not focused on the relation between alcohol drinking and brain and central nervous system cancers, and were no longer considered, whereas 68 unique publications were selected for full-text examination. Forty-seven of these publications did not report original results from cohort or case-control studies (n = 36) or investigated parental alcohol consumption in relation to childhood brain cancer (n = 11), and were therefore excluded, while 21 publications were retained for the review. The review of the reference lists of these publications resulted in the identification of six additional reports. Six publications were excluded because they were multiple reports from the same studies. Another one was excluded because the control group was composed of subjects with neoplasms other than brain cancer [25] , and was therefore not comparable to other studies. Thus, the present analyses are based on 20 publications [10-15, 18, 26-38] . Table 1 reports the main characteristics of the 19 studies (from 20 publications) included in the meta-analysis. There were 13 case-control and 6 cohort studies. Eight studies were conducted in North America, four in Europe, four in Asia and the Middle East, and three in Australia. Of 19 studies, 12 had information on total alcohol intake, 7 had data on wine drinking (two of these could not be included in the metaanalysis due to specific problems in the presentation of results in the original articles), 10 on beer (one could not be included in the meta-analysis), and 7 on spirits drinking (one could not be included). Four studies considered all brain cancers together only, eight considered only gliomas (five gliomas, two glioblastomas, and one astrocytomas), two considered only meningiomas, five considered both gliomas and meningiomas providing separate analyses for these cancer subtypes.
Overall, there were 4271 cases of brain cancer (1002 men, 1570 women, and 1699 cases in studies where men and women were analysed together). With reference to cancer subtype, 2870 cases had glioma, 749 had meningioma, and 652 had brain cancer of unspecified subtype. Figure 1 shows the study-specific and pooled RRs and 95% CIs of brain cancer for alcohol drinkers versus non-drinkers. Twelve studies were included in the analysis. Two estimates from Kim et al. [15] are shown, because the study provided separate analysis for men and women, which have been kept separate in this figure, too. Among six case-control studies, the pooled RR was 0.80 (95% CI 0.68-0.94; P for heterogeneity, 0.376). Among six cohort studies, the pooled RR was 1.11 (95% CI 0.88-1.41; P for heterogeneity, 0.026). Overall, the RR was 0.97 (95% CI 0.82-1.15; P for heterogeneity, 0.002). We excluded data of the 'clinical' control group, since it included a subgroup of subjects with meningioma. b The results for specific beverages were given as compared with non-alcohol drinkers; thus, they could not be included in the corresponding meta-analyses. The results were given only by type of wine (i.e. white, red, fortified wine); thus, they could not be included in the meta-analysis of wine drinking. Figure 2 shows the study-specific and pooled RRs and 95% CIs of brain cancer for drinkers versus non-drinkers of different types of alcoholic beverages, i.e. wine (A), beer (B) and spirits (C). One study [33] reported the results from two separate, matched analysis conducted for gliomas and meningiomas, and those estimates have been kept separate in this figure, too. With reference to wine consumption, when all the six estimates from five studies were pooled together, the RR was 1.01 (95% CI 0.70-1.48; P for heterogeneity, 0.017). Ten estimates from nine studies were available for beer consumption, and the pooled RR was 0.96 (95% CI 0.82-1.12; P for heterogeneity, 0.267). For spirits consumption, when the seven estimates from six studies were pooled together, the RR of brain cancer was 1.20 (95% CI 1.01-1.42; P for heterogeneity, 0.584). Figure 3 shows the study-specific and pooled RRs and 95% CIs of brain cancer for moderate, i.e. <2 drinks/day (A) and heavy drinking, i.e. ≥2 drinks/day (B), versus no alcohol consumption. The meta-analysis for moderate alcohol consumption included two case-control studies, with a pooled RR of 0.76 (95% CI 0.60-0.95; P for heterogeneity, 0.788), and four cohort studies (which provided five estimates) with a pooled RR of 1.15 (95% CI 0.90-1.47; P for heterogeneity, 0.118). Overall, the RR was 1.01 (95% CI 0.81-1.25; P for heterogeneity, 0.021). Four studies had data on heavy alcohol consumption. One case-control study reported a RR of 1.02 (95% CI 0.64-1.62) and three cohort studies gave a pooled RR of 1.49 (95% CI 0.83-2.69; P for heterogeneity, 0.046). Overall, the RR for heavy drinking was 1.35 (95% CI 0.85-2.15; P for heterogeneity, 0.034). Figure 4 shows the study-specific and pooled RRs and 95% CIs for alcohol drinkers versus non-drinkers for specific brain tumours, i.e. glioma (A) and meningioma (B). For gliomas, five case-control studies provided a pooled RR of 0.82 (95% CI 0.69-0.97; P for heterogeneity, 0.535), while four cohort studies provided a pooled RR of 1.03 (95% CI 0.89-1.20; P for heterogeneity, 0.525). The overall RR for glioma was 0.93 (95% CI 0.81-1.07; P for heterogeneity, 0.316). For meningiomas, Figure 3 . Forest plot for study-specific and pooled RRs and 95% CI of adult brain cancer for moderate, i.e. <2 drinks/day (A) and heavy alcohol drinking, i.e. ≥2 drinks/day (B) versus non-drinkers. CI, confidence interval; M, men; NR, nor reported; PR, persons at risk; PY, person-years; RR, relative risk; W, women.
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two case-control studies provided a pooled RR of 0.42 (95% CI 0.16-1.12; P for heterogeneity, 0.167), while three cohort studies provided a pooled RR of 0.95 (95% CI 0.69-1.32; P for heterogeneity, 0.273). The overall RR for meningioma was 0.71 (95% CI 0.45-1.12; P for heterogeneity, 0.038). Table 2 gives pooled RRs and corresponding 95% CI of adult brain cancer for alcohol drinkers versus non-drinkers in strata of selected factors. Considering subgroups of sex, the RRs were 1.65 (95% CI 1.27-2.13) among men and 0.84 (95% CI 0.63-1.12) among women. When data for men and women were given combined only, the RR was 0.87 (95% CI 0.70-1.10). Considering geographic area, the RR of alcohol drinking was 0.74 (95% CI 0.63-0.89) in five American studies. The corresponding estimates were 1.05 (95% CI 0.94-1.16) in European studies and 1.16 (95% CI 0.87-1.63) in Asian/ Australian studies. Only one study used mortality rather than incidence of brain cancer as outcome. Excluding that study, the pooled RR was 0.89 (95% CI 0.77-1.04).
The forest plot for study-specific and pooled RRs of brain cancer for alcohol drinkers versus non-drinkers according to gender is shown in Supplementary File 3, available at Annals of Oncology online. The pooled RR among men (RR = 1.65) was based on three studies. All the study-specific RRs for men were above unity, with no significant heterogeneity (P = 0.79). The corresponding RR among women (RR = 0.84) was based on five studies. Two of them found RRs above unity, and borderline heterogeneity emerged (P = 0.09). When data for men and women were given combined only, the pooled RR of 0.87 was based on seven studies. Four of them had RRs above unity, with no significant heterogeneity (P = 0.20).
Supplementary File 4, available at Annals of Oncology online shows the cumulative RRs of brain cancer for alcohol drinkers versus non-drinkers. The pooled cumulative RR was 0.85 (95% CI 0.70-1.05) for studies published up to the 1996 (five studies). The pooled RRs tended to increase throughout the period covered by data, up to the latest RR of 0.97. 
discussion
In this systematic review of epidemiological data, alcohol consumption does not appear to be associated with adult brain cancer. This finding is based on a total of 19 studies, including over 4200 cancer cases, that provided risk estimates for total alcohol or specific alcoholic beverages. There was, however, relevant heterogeneity across studies, particularly according to study design and gender. Further, limited data are available for heavy alcohol consumption, the pooled estimate indicating a moderate increase in risk for intakes of two or more drinks per day. Thus, caution is required in the interpretation of these results.
A strength of this investigation was the possibility to examine the relation with alcohol consumption separately for the main brain cancer subtypes, i.e. gliomas and meningiomas. Besides differences in the regions and cells of origin of these neoplasm subtypes, their grades of malignancy also differ, because most meningiomas are benign or low-grade tumours while gliomas are frequently highly malignant [1, 39] . Their aetiology also presents relevant differences, such as those reported for exposure to ionizing radiation (stronger association with meningioma than glioma [40] ), history of head trauma (increased risk of meningioma, but likely not glioma [33, 41] ), and selected medical conditions (associated with glioma alone [42] ). Thus, a different role of alcohol consumption was conceivable, too. Our meta-analysis for gliomas and meningiomas showed similar results and did not support any association with alcohol consumption for both subtypes. On the other hand, we were unable to analyse separately various types of glioma (e.g. glioblastoma, astrocytoma, etc.) because scanty data were available.
The largest number of studies on a specific alcoholic beverage was available for beer (n = 9). This is due to the fact that beer was a relevant dietary source of nitrosamines-which have been suspected to increase brain cancer risk-up to the late 1980s to early 1990s, when greater controls in beer making were introduced [43] . Our meta-analysis, however, does not support a role of beer drinking on adult brain cancer, providing a summary RR close to unity. There was no evidence indicating higher risks in early studies, i.e. before the decline in nitrosamine contents in beer, as the summary RR of brain cancer for beer drinking among four studies published up to 1990 was 0.79 (95% CI 0.55-1.13, though more recent studies include consumption in the past as well). Thus, our findings give little support to the N-nitroso hypothesis.
No association emerged with wine consumption, whereas we found a 20% increase in risk for spirits consumption. For the latter, the available results from different studies were fairly homogeneous and 6 of 7 point estimates were above unity, but the association was modest and was based on limited data. Further, residual confounding is possible. In the absence of associations with other beverages containing ethanol, these findings should be considered as merely indicative.
We used a relatively low cut-off for heavy drinking (i.e. ≥25 g/day, corresponding to two drinks per day). This notwithstanding, only a few studies had estimates for high alcohol consumption. Two studies reported an increased brain cancer risk in heavy drinkers and two others found no association and, overall, a moderate, non-significant increase in risk emerged, mainly based on findings from cohort studies. Similarly, prospective investigations of alcohol abusers-that were not included in the present meta-analysis because of their different approach-showed inconsistent results for nervous Annals of Oncology original articles system cancers, reporting no association in Denmark (RR = 0.7, based on 22 cases) [44] and Sweden (standardized incidence ratio = 1.4 for men and women combined, based on 15 cases) [45] , and an increased mortality in Italy (standardized mortality ratio = 2.7, based however on four deaths only) [46] . Thus, the overall RR for alcoholics from these studies was 0.91 (95% CI 0.65-1.24, based on 41 observed and 45 expected cases). The issue remains therefore open to discussion. Observational studies included in our meta-analysis may be affected by various sources of bias that, at least in part, may explain the lower pooled RR observed in case-control than in cohort studies. An important issue concerns the assessment of alcohol or specific alcoholic beverages consumption, which is based on patients' self-reporting. However, reproducibility of alcohol consumption was acceptable in studies from Europe [47] and North America [48] and reporting should not be different among cases and controls, as alcohol is not known to be associated to brain cancer. However, a reduction in alcohol consumption because of early symptoms of brain cancer in cases might explain the moderate inverse association observed in case-control studies only, since these consider more recent exposures, as contrasted with the absence of association in cohort studies. The few available data limited the scope for dose-risk analyses. However, several papers have been published recently [11] [12] [13] [14] [15] , allowing a meaningful investigation of the role of total alcohol drinking on the risk of brain cancer. 
